NCT00047489View on ClinicalTrials.gov

Study of ABT-751 in Patients With Refractory Hematologic Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
Hematological Malignancies
Interventions
DRUG

ABT-751

Trial Locations (1)

77030

The University of Texas M.D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00047489 - Study of ABT-751 in Patients With Refractory Hematologic Malignancies | Biotech Hunter | Biotech Hunter